Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. Standard BioTools Inc. has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Gajus Worthington

Standard BioTools Inc.

Standard BioTools develops and offers a variety of tools and technologies for biological research, including instruments and reagents for mass cytometry and genomics analysis. It also provides support and scientific consultation services.

Standard BioTools

Standard BioTools | 32,290 followers on LinkedIn. Providing essential, standardized tools to accelerate breakthroughs in human health
Microfluidics | Cytometry | Imaging | Standard BioTools delivers the leading proteomic and multi-omic solutions that enable researchers to discover unique biological insights not accessible by other technologies.

Manager, Commercial Applications | MBA, IT, CRM, Healthcare, Lab, Digital Transformation, Innovation

Chris Ward

Senior Vice President, Global Research and Development

David King

Emilia Costales

Amber (Kessinger) Faust

Today at the Society for Immunotherapy of Cancer (SITC) ! Learn more about our exciting collaboration with Surge to combine artificial intelligence with our industry-leading flow and mass cytometry technologies to help researchers quickly analyze data and find predictive biomarkers. Stop by SITC Booth 601 for a demo to see how this new partnership will revolutionize your research. #SITC24 #AI #Biomarkers

Did you know? Our high-content platforms in serum, spatial, and single-cell -omics offer the highest levels of content, precision and unique scalability in the life science industry. Learn how at the Saturday #SITC24 poster session! And see more of what’s happening at SITC: https://lnkd.in/g5s4GPB9

We love that you love #ASHG24 ! What an incredible event – meeting new people, engaging in interesting conversations and sharing in your excitement about what’s new in genetics. If you haven’t yet, stop by Booth 145 to meet the team and learn how multi-omic research is paving the way for precision medicine and better disease management. (and maybe grab some popcorn…) Check here for information on posters and updates: https://lnkd.in/gPVZvyhM and https://lnkd.in/gpcXcXPn #genetics #proteogenomics #pharmacogenomics

As we continue to expand our offerings and services to support life science researchers, we’re excited to introduce our new brand. Our new branding reflects our commitment to advancing breakthroughs in biological insights and moving human health forward. If you’re attending the Society for Immunotherapy of Cancer (SITC) Annual Meeting in Houston, TX, this week, stop by our Booth (601) to be among the first to experience it in real life. #SITC24 #ImmunoOncology #Proteomics #Genomics #LifeScienceResearch

We're proud to be recognized by Genetic Engineering & Biotechnology News as one of the Top 10 Spatial Biology Companies of 2024! 🎉 You can read about this amazing list here: https://lnkd.in/gNMTn6_M Unlock a new view in spatial biology. Take the first step and book a virtual demo to learn more about our Hyperion XTi™ Imaging System: https://lnkd.in/eDX5r8_r

Take a look through a neuroscience lookbook! Understanding cellular and spatial composition of tissues is crucial for interpreting neural disease origin, progression, prognosis and treatment options… https://lnkd.in/giECekUW This lookbook contains case studies that evaluate neuro-oncology and neurodegenerative diseases, highlighting the ability to generate spatial maps of tissue structures and visualize immune cell activity and infiltration using Imaging Mass Cytometry™ for simultaneous detection of protein markers. Using a combination of imaging modes and ready-to-go high-plex panels on the same tissue section provides researchers with more flexibility to resolve the distribution of neural and non-neural cell lineages. See for yourself! Send us your samples, and we’ll run any of our panels for you: https://lnkd.in/gywMZubZ #neurology #imaging

We’re excited to be in Denver at #ASHG24 today, bringing our suite of multi-omic solutions and their unique ability to drive #PopulationHealth insights. Visit us at booth #145 or, if you are avoiding Denver’s snowstorm today, learn more online: https://lnkd.in/eRDsYF8u

If you are in Denver for #ASHG24 , don’t miss this special Industry Education Session! Hear about cutting-edge advancements in pharmacogenomics, emphasizing the utilization of nanoscale genomics to achieve comprehensive coverage of Association for Molecular Pathology (AMP) Tier 1 targets across a range of therapeutic areas. Get a seat: https://lnkd.in/gkpeqCc9 More on the event: https://lnkd.in/gPVZvyhM

Join the discussion at #SITC24 ! Standard BioTools offers leading proteomics and multi-omics solutions that scale. See how in the Friday poster session, and learn how to gain a better understanding of cellular heterogeneity in brain tumors, visualize the immunological spatial landscape in mouse neural tissues and capture CAR T cell function. See more of what’s happening at SITC: https://lnkd.in/g5s4GPB9 Need help with region selection for your imaging projects? We’ve got a poster on a deep-learning approach for that, too! Take a look on Friday, November 8, at 5:30–7:00pm...

The agenda is out! We are thrilled to announce the speakers for the 1st Iberian #CyTOF Congress. Join the discussion about the role of mass cytometry in cell analysis and large-scale immune profiling, covering treatment failure in B-cell acute lymphoblastic leukemia, immunophenotyping systemic autoimmune disease, neuroinflammation in multiple sclerosis, multi-omic cancer datasets and much more… See the agenda and save your complimentary spot: https://lnkd.in/g5is9JAK #immuneprofiling #spatialprofiling #cellbarcoding #spatialbiology

Metric
Company Name	Standard BioTools Inc.
Symbol	LAB
MSH ID	COM:FLUIDIGM
Market	STOCKS
Sector	Healthcare
Industry	Medical - Diagnostics & Research
Country	US
Stage
Employee Count	534
Website	fluidigm.com
LinkedIn
Founders

Metric
Market Cap	651.94M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	106.34M
Revenue (LTM)
Revenue (NTM)
Gross Profit	50.45M
EBITDA	-47.86M
Operating Income	-63.04M
Net Income	-74.66M
EPS	-0.94
Diluted EPS	-0.94
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.49
Operating Profit Margin	-0.66
EBITDA Margin	-0.45
Net Profit Margin	-0.70
Return on Equity	1.67
Return on Assets	-0.12
Return on Capital Employed	-0.14

COM:FLUIDIGM

Standard BioTools

Last Close

1.62

22/11 21:00

Market Cap

651.94M

Beta: -

Volume Today

1.42M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-2.57
P/B Ratio	-1.48
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	9.26
EV Multiple	-6.21

Metric
Days Sales Outstanding	57.47
Days Payables Outstanding	46.82
Days Inventory Outstanding	228.53
Operating Cycle	332.22
Cash Conversion Cycle	257.81
Asset Turnover	0.33

Metric
Operating Cash Flow	-43.29M
Free Cash Flow	-46.12M
Cash Flow to Debt	-0.64
Operating Cash Flow/Sales	-0.41
Free Cash Flow Yield	-0.06

Metric
Cash & Equivalents	51.70M
Accounts Receivable	-2.99M
Inventory	20.53M
Goodwill	106.32M
Debt to Capitalization	0.29
Debt to Assets	0.29
Current Ratio	3.30
Quick Ratio	4.17

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.08
R&D to Revenue	0.26
SG&A to Revenue